Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistance

Miniatura

Archivos

Miller_Corwin_2013.pdf (1.56 MB)

Fecha

2013

Autores

Título de la revista

Publicado en

Antimicrobial Agents and Chemotherapy, 1098-6596, Vol. 57, No. 11, 2013 p. 5373-5383

Publicado por

American Society for Microbiology

URI

https://hdl.handle.net/20.500.12495/3557

URL de la fuente

https://aac.asm.org/content/58/1/631

Enlace a contenidos multimedia

ISSN de la revista

Título del volumen

Resumen

Descripción

Abstract

With increasing numbers of hospital-acquired antibiotic resistant infections each year and staggering health care costs, there is a clear need for new antimicrobial agents, as well as novel strategies to extend their clinical efficacy. While genomic studies have provided a wealth of information about the alleles associated with adaptation to antibiotics, they do not provide essential information about the relative importance of genomic changes, their order of appearance, or potential epistatic relationships between adaptive changes. Here we used quantitative experimental evolution of a single polymorphic population in continuous culture with whole-genome sequencing and allelic frequency measurements to study daptomycin (DAP) resistance in the vancomycin-resistant clinical pathogen Enterococcus faecalis S613. Importantly, we sustained both planktonic and nonplanktonic (i.e., biofilm) populations in coculture as the concentration of antibiotic was raised, facilitating the development of more ecological complexity than is typically observed in laboratory evolution. Quantitative experimental evolution revealed a clear order and hierarchy of genetic changes leading to resistance, the signaling and metabolic pathways responsible, and the relative importance of these mutations to the evolution of DAP resistance. Despite the relative simplicity of this ex vivo approach compared to the ecological complexity of the human body, we showed that experimental evolution allows for rapid identification of clinically relevant adaptive molecular pathways and new targets for drug design in pathogens.

Palabras clave

Keywords

Temáticas

Enterococcus faecalis
Daptomicina
Farmacorresistencia fúngica

Citación

Colecciones

Artículos